Article
Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.
Cancer research - 1 Mar 2018
Peng Hongzhuang, Prokop Jeremy, Karar Jayashree, Park Kyewon, Cao Li, Harbour J William, Bowcock Anne M, Malkowicz S Bruce, Cheung Mitchell, Testa Joseph R, Rauscher Frank J
Abstract excerpt
Deleterious mutations of the ubiquitin carboxy-terminal hydrolase BAP1 found in cancers are predicted to encode inactive truncated proteins, suggesting that loss of enzyme function is a primary tumorigenic mechanism. However, many tumors exhibit missense mutations or in-frame deletions or insertions, often outside the functionally critical UCH domain in this tumor suppressor protein. Thus, precisely how these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
